Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why ...

Ten leading biopharmaceutical companies have formed a non-profit organisation to accelerate the development of new ... FDA's Center for Drug Evaluation and Research. The idea for TransCelerate ...

Too often, the disconnect between a company’s IT department and its business teams slows progress and leads to missed opportunities. In the fast-moving pharmaceutical industry, that can mean the ...

During a recent panel discussion sponsored by Purdue University, industry leaders explain how the technology is revolutionizing drug development and production ...

Pharmaceutical leaders must anticipate the changes in the regulatory landscape to stay ahead and quickly integrate compliance strategies into their long-term research and development (R&D ...

more intricate and complex research areas, macroeconomic factors, tech advancements and high attrition rates; the pharma cohort spent $7.7 billion on trials for candidates that were terminated in ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma ... to prevent the development of exhaustion by T cells enabling them to continue to kill tumor cells.” Dr. Ram Murali, VP of Research and Development ...

“We have several prescription products in development ... will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I CDMO growth strategy.

Fort Lee, NJ, March 26, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of ...